Di Perri G - Search Results

1

Raltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and Pharmacokinetics.

Calcagno A, Montrucchio C, Capetti A, Guaraldi G, Cenderello G, Calza L, Lanzafame M, Marinaro L, Tettoni MC, Trentini L, D'Avolio A, Di Perri G, Bonora S. Calcagno A, et al. Among authors: di perri g. Curr HIV Res. 2016;14(1):54-60. doi: 10.2174/1570162x13666150929112135. Curr HIV Res. 2016. PMID: 26415700

2

Quinine-induced blindness reversed by an increase in alpha1-acid glycoprotein level.

Di Perri G, Allegranzi B, Bonora S. Di Perri G, et al. Ann Intern Med. 2002 Feb 19;136(4):339. doi: 10.7326/0003-4819-136-4-200202190-00016. Ann Intern Med. 2002. PMID: 11848734 No abstract available.

3

Tuberculosis and treatment with infliximab.

De Rosa FG, Bonora S, Di Perri G. De Rosa FG, et al. Among authors: di perri g. N Engl J Med. 2002 Feb 21;346(8):623-6. N Engl J Med. 2002. PMID: 11859882 Free article. No abstract available.

4

Alpha 1-acid glycoprotein levels in human immunodeficiency virus-infected subjects on antiretroviral regimens.

Boffito M, Sciole K, Raiteri R, Bonora S, Hoggard PG, Back DJ, Di Perri G. Boffito M, et al. Among authors: di perri g. Drug Metab Dispos. 2002 Jul;30(7):859-60. doi: 10.1124/dmd.30.7.859. Drug Metab Dispos. 2002. PMID: 12132432 No abstract available.

5

The unbound percentage of saquinavir and indinavir remains constant throughout the dosing interval in HIV positive subjects.

Boffito M, Hoggard PG, Reynolds HE, Bonora S, Meaden ER, Sinicco A, Di Perri G, Back DJ. Boffito M, et al. Among authors: di perri g. Br J Clin Pharmacol. 2002 Sep;54(3):262-8. doi: 10.1046/j.1365-2125.2002.01663.x. Br J Clin Pharmacol. 2002. PMID: 12236846 Free PMC article.

6

Simultaneous determination of rifampicin and efavirenz in plasma.

Boffito M, Tija J, Reynolds HE, Hoggard PG, Bonora S, Di Perri G, Back DJ. Boffito M, et al. Among authors: di perri g. Ther Drug Monit. 2002 Oct;24(5):670-4. doi: 10.1097/00007691-200210000-00015. Ther Drug Monit. 2002. PMID: 12352941

7

Clinical use of lopinavir/ritonavir in a salvage therapy setting: pharmacokinetics and pharmacodynamics.

Boffito M, Arnaudo I, Raiteri R, Bonora S, Sinicco A, Di Garbo A, Reynolds HE, Hoggard PG, Back DJ, Di Perri G. Boffito M, et al. Among authors: di perri g, di garbo a. AIDS. 2002 Oct 18;16(15):2081-3. doi: 10.1097/00002030-200210180-00015. AIDS. 2002. PMID: 12370509

8

Pharmacokinetics of saquinavir co-administered with cimetidine.

Boffito M, Carriero P, Trentini L, Raiteri R, Bonora S, Sinicco A, Reynolds HE, Hoggard PG, Back DJ, Di Perri G. Boffito M, et al. Among authors: di perri g. J Antimicrob Chemother. 2002 Dec;50(6):1081-4. doi: 10.1093/jac/dkf232. J Antimicrob Chemother. 2002. PMID: 12461038

9

Healthy ranges for alanine aminotransferase levels.

De Rosa FG, Bonora S, Di Perri G. De Rosa FG, et al. Among authors: di perri g. Ann Intern Med. 2003 Jan 21;138(2):156-7; author reply 156-7. doi: 10.7326/0003-4819-138-2-200301210-00021. Ann Intern Med. 2003. PMID: 12529101 No abstract available.

10

Lopinavir protein binding in vivo through the 12-hour dosing interval.

Boffito M, Hoggard PG, Lindup WE, Bonora S, Sinicco A, Khoo SH, Di Perri G, Back DJ. Boffito M, et al. Among authors: di perri g. Ther Drug Monit. 2004 Feb;26(1):35-9. doi: 10.1097/00007691-200402000-00008. Ther Drug Monit. 2004. PMID: 14749547 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

728 results

Search Page

Filters